Cardioprotective Actions by a Water‐Soluble Carbon nMonoxide‐Releasing Molecule

By James E. Clark, P. Naughton, S. Shurey, C. Green, Tony R. Johnson, B. Mann, R. Foresti, R. Motterlini. Circulation Research, 2003

621 citations recorded by the source corpus.

Subfields: Cell Biology, Molecular Biology, Pediatrics, Perinatology and Child Health

View Paper: https://www.semanticscholar.org/paper/dafc1049efab286c795d7fac6680f2f78bed727a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cell Biology

1. A. Kappas
2. Nader G. Abraham

In Molecular Biology

1. Rui Wang
2. A. Kappas
3. Nader G. Abraham
4. Lingyun Wu
5. S. Ryter
6. A. Choi
7. J. Alam
8. R. Motterlini

In Pediatrics, Perinatology and Child Health

1. A. Kappas
2. Nader G. Abraham
3. Rui Wang
4. R. Motterlini
5. L. Otterbein

Citations in the corpus

• Pharmacological and Clinical Aspects of Heme Oxygenase (2008, positive): “CO also protects isolated hearts against ischemiareperfusion (Clark et al., 2003).”
• Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications (2005, methodology): “CORM-3 has several advantages over the first generation of CORMs.”
• Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. (2006, background): “In light of the general protective properties of the HO-1/HO-2 system, and the possible therapeutic applications of CO gas, as detailed for several disease applications in the subsequent sections, Motterlini and colleagues (112, 186, 459, 460, 464) have developed a novel class of chemical compounds ”
• The therapeutic potential of carbon monoxide (2010, neutral): “CO-RM3 ([Ru(CO) 3 Cl-glycinato]) and CO-RMA1 (Na 2 [H 3 BCO 2 ]) are examples of water-soluble CO-releasing agent”